No Data
No Data
Stocks that moved the previous day, part 1: 7&iHD, Shionogi & Co., Ltd., Double A, etc.
Stock name <code>19 closing price ⇒ comparison with the previous dayAsuka Pharmaceutical HD <4886> 2,309 + 21 Obtained approval for manufacturing and selling oral contraceptive drospirenone in South Korea. In the afternoon, the increase narrowed. 7&iHD <3382> 2,161 + 400 Acquired proposal reported from Canada's largest convenience store chain, Alimentation Couche-Tard. Renascience <4889> 353 + 14 Clinical performance tests of AI to predict insulin dosage for diabetes patients have started. Economic <3802>
The Tokyo Stock Exchange Growth Market Index has risen for 9 consecutive days, showing relative stability.
Tokyo Stock Exchange Growth Market Index 786.35 +2.40 / volume 0.3533 billion shares / trading value 139 billion yen Tokyo Stock Exchange Growth Market 250 Index 612.03 +2.92 /volume 0.2502 billion shares / trading value 111.4 billion yen Today's growth market, the Tokyo Stock Exchange Growth Market Index has risen for 9 consecutive days, and the Tokyo Stock Exchange Growth Market 250 Index has also risen. The number of rising stocks is 206, the number of falling stocks is 348, and unchanged is 34. On the 16th, the Dow Jones Industrial Average rose 96.70 dollars to 40659.
Active and newly established stocks in the afternoon session.
*Asuka Pharmaceutical HD <4886> 2309 + 21 has obtained approval for manufacturing and sales of the oral contraceptive Drospirenone in South Korea. In the afternoon, the increase narrowed. *7 & i HD <3382> 2161 + 400 reported acquisition proposal from Canadian convenience store giant Alimentation Couche-Tard. *Renascience <4889> 353 + 14 clinical performance tests of AI predicting insulin dosage for diabetic patients has started. *Economic <3802> 435 + 15100 shares or more.
Emerging market stock digest: Astroscale, Shinbio Pharmaceutical hit the limit.
<186A> Astro Scale Co., Ltd. rose by 150 points to 934, having announced to have signed a large contract for JAXA's (Japan Aerospace Exploration Agency) Commercial Removal of Debris Demonstration (CRD2) Phase II through subsidiary Astro Scale. The contract amount is JPY 1.2 billion (excluding tax) and the contract period will be until the end of March 29. The income has been priced in for the full year consolidated financial estimates for the year ending in April 2025 (project income), but it will be recognized over the contract period.
Hot stocks digest (morning): Sumitomo Pharmaceuticals, Double A, Pan Pacific HD, etc.
MH Group <9439>: 196 yen (-7 yen) significant decline. They announced their financial results for the year ending June 24th after the end of the previous week's trading. Operating profit was 0.023 billion yen, a 57.5% decrease from the previous year. It seems to have been disappointed that it fell to a deficit, about 64% lower than the previous estimate of 0.065 billion yen. This is due to the PB product sales in the BS salon operating business being below expectations, as well as an increase in cost of sales and personnel expenses. Operating profit for the year ending June 25th is 0.03 billion yen, up 29.6% from the previous year.
Double-A--- shares sharply rise as company announces stock splits and expansion of shareholder benefits program.
Sharply rose. After the close of trading on the 16th, it was announced that the company will expand its stock splits and shareholder benefit program, which has been well-received. It announced that it will split one share into two based on August 31. The expansion of benefits will be extended to bags and shoe care products in addition to shoes, and the brands eligible for shareholder benefits, which were uniform for shareholders holding one unit (100 shares) or more, will be expanded to include Himiko and NICAL for shareholders holding six units (600 shares) or more after the stock split.
No Data